Does 'brain training' work?

In a large-scale systematic review and meta-analysis published in PLoS Medicine, researchers at the Regenerative Neuroscience group have found that cognitive training is effective in healthy older adults. However, benefits can be achieved only when cognitive training is conducted in group settings and no more than three times per week. Read more

Click here to see the feature on ABC 730

Click here to read the Sydney Sun Herald story


Help RNG beat dementia

The Regenerative Neuroscience Group is pioneering a radical new treatment to beat dementia based on a person’s own stem cells. We have successfully tested this technology in rats and are now moving on to human research. See below for our short film about this exciting project. We aim to raise $250,000 towards this goal through public support, including crowd funding.

To learn more about how you can contribute to beating dementia click here

To learn more about the DOGS+CELLS Trial that aims to beat doggie dementia click here

World first: RNG team reverse dog dementia with stem cell therapy

The tale of Timmy the Wonderdog isn’t just a comeback story to warm the hearts of dog lovers, it’s a breakthrough that could offer real hope to millions of people affected by dementia. RNG researchers have successfully reversed signs of dementia in 13-year old Timmy by injecting him with his own stem cells.

See our Channel 10 panel appearance here

See a longer video about Timmy the Wonderdog here

Read more about the story here

RNG Strategic Research Program

Dogs have the most plastic genome of any animal. They have shared our environments and experiences for at least 14,000 years, and this period of co-evolution has produced dramatic changes to canine morphology, brain organization, behavioural attributes and genetic diversity. Remarkably, in their later years dogs also develop a form of dementia called Canine Cognitive Dysfunction, and this is now a major research focus of RNG. Read more.

The DOGS+CELLS Trial is currently recruiting doggie dementia patients for this world-first study. Learn more here